Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
62.70
-0.20 (-0.32%)
Aug 12, 2025, 1:30 PM CST
Silk Road Medical Revenue
Johnson Chemical Pharmaceutical Works had revenue of 138.19M TWD in the quarter ending June 30, 2025, a decrease of -8.12%. This brings the company's revenue in the last twelve months to 582.81M, down -5.44% year-over-year. In the year 2024, Johnson Chemical Pharmaceutical Works had annual revenue of 611.42M with 0.78% growth.
Revenue (ttm)
582.81M
Revenue Growth
-5.44%
P/S Ratio
4.85
Revenue / Employee
3.49M
Employees
171
Market Cap
2.83B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 611.42M | 4.70M | 0.78% |
Dec 31, 2023 | 606.71M | 112.04M | 22.65% |
Dec 31, 2022 | 494.67M | 83.18M | 20.21% |
Dec 31, 2021 | 411.49M | -12.52M | -2.95% |
Dec 31, 2020 | 424.02M | -1.32M | -0.31% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 40.47M |
PharmaEssentia | 11.34B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lotus Pharmaceutical | 19.12B |
Oneness Biotech | 112.57M |
Polaris Group | 87.67M |
Center Laboratories | 1.63B |
Pegavision | 6.67B |